Biodesix (BDSX) Current Leases (2022 - 2026)

Biodesix (BDSX) has 5 years of Current Leases data on file, last reported at $1.5 million in Q1 2026.

• Quarterly Current Leases rose 32.72% year-over-year to $1.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.5 million (up 32.72% YoY) and the FY2025 annual result came in at $1.4 million, up 89.71% from the prior year.
• Current Leases rose to $1.5 million in Q1 2026, from $1.4 million in the prior quarter.
• In the past five years, Current Leases ranged from a high of $1.8 million in Q1 2023 to a low of $252000.0 in Q4 2023.
• A 5-year average of $1.1 million and a median of $1.2 million in 2025 frame the typical range for Current Leases.
• Annual changes were most pronounced in 2024 — Current Leases tumbled 84.56% — and 2025, when it jumped 310.67%.
• Tracing BDSX's Current Leases over 5 years: stood at $1.5 million in 2022, then plunged by 83.67% to $252000.0 in 2023, then jumped by 185.32% to $719000.0 in 2024, then surged by 89.71% to $1.4 million in 2025, then advanced by 6.45% to $1.5 million in 2026.
• The last three Current Leases figures came in at $1.5 million (Q1 2026), $1.4 million (Q4 2025), and $1.4 million (Q3 2025), per Business Quant data.